| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.532 | 0.001 | 0.532 | 5 Hydroxytryptamine 1D agonist | 0.416 0.002 DBMET00088 0.137 0.003 DBMET00089 | ||
| 0.509 | 0.004 | 0.509 | 5 Hydroxytryptamine 1 agonist | 0.436 0.005 DBMET00088 0.222 0.01 DBMET00089 | ||
| 0.51 | 0.026 | 0.588 | 5 Hydroxytryptamine release stimulant | 0.588 0.016 DBMET00088 0.232 0.099 DBMET00089 | DBMET00088 | |
| 0.454 | 0.003 | 0.454 | 5 Hydroxytryptamine 1B agonist | 0.32 0.004 DBMET00088 0.174 0.004 DBMET00089 | ||
| 0.482 | 0.035 | 0.512 | Calcium channel L-type activator | 0.512 0.024 DBMET00088 0.472 0.04 DBMET00089 | DBMET00088 | |
| 0.454 | 0.064 | 0.64 | Analgesic | 0.327 0.122 DBMET00088 0.64 0.02 DBMET00089 | DBMET00089 | |
| 0.373 | 0.005 | 0.402 | 5 Hydroxytryptamine agonist | 0.402 0.005 DBMET00088 0.134 0.025 DBMET00089 | DBMET00088 | |
| 0.328 | 0.004 | 0.328 | 5 Hydroxytryptamine 1B antagonist | 0.135 0.015 DBMET00088 | ||
| 0.328 | 0.004 | 0.328 | 5 Hydroxytryptamine 1D antagonist | 0.152 0.011 DBMET00088 | ||
| 0.304 | 0.005 | 0.304 | 5 Hydroxytryptamine 1F antagonist | 0.202 0.01 DBMET00088 0.087 0.039 DBMET00089 | ||
| 0.336 | 0.039 | 0.426 | Insulysin inhibitor | 0.426 0.018 DBMET00088 0.283 0.069 DBMET00089 | DBMET00088 | |
| 0.307 | 0.018 | 0.307 | 5 Hydroxytryptamine antagonist | 0.181 0.039 DBMET00088 0.103 0.076 DBMET00089 | ||
| 0.329 | 0.042 | 0.381 | Interleukin antagonist | 0.381 0.034 DBMET00088 0.238 0.066 DBMET00089 | DBMET00088 | |
| 0.361 | 0.082 | 0.432 | Antiobesity | 0.432 0.055 DBMET00088 0.379 0.074 DBMET00089 | DBMET00088 | |
| 0.292 | 0.035 | 0.292 | 5 Hydroxytryptamine 1E antagonist | 0.231 0.095 DBMET00088 0.213 0.116 DBMET00089 | ||
| 0.24 | 0.004 | 0.24 | 5 Hydroxytryptamine 6 antagonist | 0.195 0.004 DBMET00088 0.065 0.032 DBMET00089 | ||
| 0.214 | 0.004 | 0.214 | Neurokinin antagonist | 0.07 0.02 DBMET00088 0.071 0.019 DBMET00089 | ||
| 0.258 | 0.061 | 0.264 | Tyrosine 3 hydroxylase inhibitor | 0.264 0.056 DBMET00088 0.179 0.178 DBMET00089 | DBMET00088 | |
| 0.196 | 0.004 | 0.196 | Neurokinin 2 antagonist | 0.075 0.015 DBMET00088 | ||
| 0.224 | 0.032 | 0.228 | 5 Hydroxytryptamine 3E antagonist | 0.228 0.029 DBMET00088 0.189 0.084 DBMET00089 | DBMET00088 | |
| 0.196 | 0.019 | 0.196 | Falcipain 3 inhibitor | 0.157 0.033 DBMET00088 0.111 0.061 DBMET00089 | ||
| 0.179 | 0.004 | 0.179 | Neurokinin 1 antagonist | 0.044 0.024 DBMET00088 0.051 0.018 DBMET00089 | ||
| 0.202 | 0.041 | 0.229 | Cyclooxygenase inhibitor | 0.229 0.031 DBMET00088 0.175 0.053 DBMET00089 | DBMET00088 | |
| 0.185 | 0.03 | 0.185 | Nav1.3 sodium channel blocker | 0.163 0.04 DBMET00088 | ||
| 0.163 | 0.011 | 0.178 | Somatostatin 1 agonist | 0.178 0.009 DBMET00088 0.152 0.013 DBMET00089 | DBMET00088 | |
| 0.165 | 0.028 | 0.174 | Nav1.4 sodium channel blocker | 0.174 0.025 DBMET00088 0.151 0.033 DBMET00089 | DBMET00088 | |
| 0.137 | 0.002 | 0.137 | 5 Hydroxytryptamine 6 agonist | 0.123 0.002 DBMET00088 0.042 0.007 DBMET00089 | ||
| 0.138 | 0.004 | 0.193 | Growth hormone secretagogue receptor agonist | 0.193 0.004 DBMET00088 0.116 0.005 DBMET00089 | DBMET00088 | |
| 0.123 | 0.004 | 0.123 | Neurokinin 3 antagonist | 0.039 0.038 DBMET00088 | ||
| 0.159 | 0.041 | 0.159 | 5 Hydroxytryptamine 2 antagonist | 0.096 0.075 DBMET00088 0.085 0.084 DBMET00089 | ||
| 0.116 | 0.004 | 0.126 | DNA helicase inhibitor | 0.126 0.004 DBMET00088 0.113 0.004 DBMET00089 | DBMET00088 | |
| 0.129 | 0.022 | 0.15 | Metalloproteinase-9 inhibitor | 0.15 0.015 DBMET00088 0.074 0.05 DBMET00089 | DBMET00088 | |
| 0.108 | 0.007 | 0.264 | Somatostatin agonist | 0.264 0.005 DBMET00088 0.077 0.009 DBMET00089 | DBMET00088 | |
| 0.154 | 0.054 | 0.181 | Cyclooxygenase 1 inhibitor | 0.181 0.043 DBMET00088 0.128 0.073 DBMET00089 | DBMET00088 | |
| 0.111 | 0.012 | 0.111 | CC chemokine 5 receptor agonist | 0.108 0.015 DBMET00088 0.087 0.043 DBMET00089 | ||
| 0.154 | 0.056 | 0.154 | Neurotrophic factor | 0.129 0.081 DBMET00088 | ||
| 0.225 | 0.13 | 0.23 | Nootropic | 0.23 0.125 DBMET00088 0.221 0.133 DBMET00089 | DBMET00088 | |
| 0.129 | 0.034 | 0.129 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.119 | 0.03 | 0.149 | Metalloproteinase-2 inhibitor | 0.149 0.019 DBMET00088 0.07 0.065 DBMET00089 | DBMET00088 | |
| 0.091 | 0.007 | 0.102 | Somatostatin 5 antagonist | 0.102 0.006 DBMET00088 0.074 0.009 DBMET00089 | DBMET00088 | |
| 0.14 | 0.056 | 0.14 | Acetylcholine antagonist | 0.119 0.072 DBMET00088 | ||
| 0.14 | 0.058 | 0.14 | Cholinergic antagonist | 0.118 0.075 DBMET00088 0.13 0.065 DBMET00089 | ||
| 0.088 | 0.008 | 0.1 | Somatostatin 1 antagonist | 0.1 0.007 DBMET00088 0.08 0.009 DBMET00089 | DBMET00088 | |
| 0.14 | 0.062 | 0.16 | Cyclooxygenase 2 inhibitor | 0.16 0.047 DBMET00088 0.127 0.073 DBMET00089 | DBMET00088 | |
| 0.084 | 0.008 | 0.114 | Somatostatin 2 antagonist | 0.114 0.006 DBMET00088 0.073 0.009 DBMET00089 | DBMET00088 | |
| 0.128 | 0.053 | 0.128 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.109 | 0.035 | 0.109 | Dopamine antagonist | 0.067 0.057 DBMET00089 | ||
| 0.089 | 0.014 | 0.089 | Nicotinic receptor alpha7 subunit antagonist | 0.061 0.027 DBMET00088 | ||
| 0.114 | 0.045 | 0.114 | Falcipain 2 inhibitor | 0.102 0.051 DBMET00088 | ||
| 0.116 | 0.046 | 0.116 | Falcipain inhibitor | 0.103 0.053 DBMET00088 | ||
| 0.072 | 0.007 | 0.093 | Somatostatin 5 agonist | 0.093 0.005 DBMET00088 0.065 0.008 DBMET00089 | DBMET00088 | |
| 0.105 | 0.042 | 0.105 | 5 Hydroxytryptamine 2C antagonist | 0.092 0.051 DBMET00088 | ||
| 0.096 | 0.034 | 0.096 | Dopamine D2 antagonist | 0.062 0.048 DBMET00089 | ||
| 0.091 | 0.031 | 0.114 | Matrix metalloproteinase inhibitor | 0.114 0.021 DBMET00088 | DBMET00088 | |
| 0.189 | 0.129 | 0.291 | Spasmolytic | 0.291 0.074 DBMET00089 | DBMET00089 | |
| 0.1 | 0.04 | 0.1 | Acetylcholine nicotinic antagonist | 0.098 0.04 DBMET00088 | ||
| 0.26 | 0.201 | 0.309 | Cyclophilin D inhibitor | 0.309 0.154 DBMET00088 | DBMET00088 | |
| 0.096 | 0.038 | 0.096 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.064 | 0.01 | 0.064 | Substance P antagonist | 0.037 0.03 DBMET00088 0.05 0.017 DBMET00089 | ||
| 0.085 | 0.032 | 0.085 | Neuronal nicotinic receptor antagonist | 0.085 0.032 DBMET00088 | ||
| 0.064 | 0.014 | 0.075 | Growth hormone release inhibitor | 0.075 0.01 DBMET00088 0.059 0.016 DBMET00089 | DBMET00088 | |
| 0.101 | 0.054 | 0.101 | Prolactin inhibitor | |||
| 0.072 | 0.025 | 0.084 | Matrix metalloproteinase 1 inhibitor | 0.084 0.019 DBMET00088 | DBMET00088 | |
| 0.087 | 0.041 | 0.087 | Alpha 1b adrenoreceptor antagonist | |||
| 0.052 | 0.014 | 0.088 | Somatostatin 4 agonist | 0.088 0.008 DBMET00088 0.04 0.022 DBMET00089 | DBMET00088 | |
| 0.065 | 0.028 | 0.082 | Matrix metalloproteinase (membrane-type) inhibitor | 0.082 0.019 DBMET00088 | DBMET00088 | |
| 0.048 | 0.017 | 0.048 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.065 | 0.034 | 0.065 | Prolactin release inhibitor | |||
| 0.039 | 0.009 | 0.053 | Somatostatin 4 antagonist | 0.053 0.008 DBMET00088 0.034 0.01 DBMET00089 | DBMET00088 | |
| 0.053 | 0.026 | 0.065 | Melanocortin antagonist | 0.065 0.018 DBMET00088 0.045 0.036 DBMET00089 | DBMET00088 | |
| 0.036 | 0.009 | 0.036 | 5 Hydroxytryptamine 1F agonist | |||
| 0.054 | 0.028 | 0.054 | Glycine transporter inhibitor | 0.043 0.038 DBMET00088 | ||
| 0.049 | 0.024 | 0.068 | Melanocortin 4 antagonist | 0.068 0.016 DBMET00088 0.04 0.031 DBMET00089 | DBMET00088 | |
| 0.127 | 0.101 | 0.144 | MAP3K9 inhibitor | 0.144 0.069 DBMET00088 | DBMET00088 | |
| 0.03 | 0.005 | 0.109 | Somatostatin 2 agonist | 0.109 0.004 DBMET00088 0.021 0.006 DBMET00089 | DBMET00088 | |
| 0.044 | 0.02 | 0.044 | Histone deacetylase 9 inhibitor | 0.043 0.021 DBMET00088 | ||
| 0.059 | 0.035 | 0.093 | Cannabinoid CB2 receptor agonist | 0.093 0.021 DBMET00089 | DBMET00089 | |
| 0.032 | 0.009 | 0.041 | Somatostatin 3 antagonist | 0.041 0.008 DBMET00088 0.026 0.01 DBMET00089 | DBMET00088 | |
| 0.052 | 0.029 | 0.052 | Nicotinic receptor alpha4 subunit antagonist | |||
| 0.124 | 0.102 | 0.124 | Acetylcholine M1 receptor antagonist | |||
| 0.074 | 0.053 | 0.074 | Acetylcholine M4 receptor antagonist | |||
| 0.041 | 0.022 | 0.042 | Histone deacetylase 7 inhibitor | 0.042 0.022 DBMET00088 | DBMET00088 | |
| 0.09 | 0.071 | 0.09 | Alpha 2d adrenoreceptor antagonist | |||
| 0.072 | 0.055 | 0.072 | Alpha 2a adrenoreceptor antagonist | |||
| 0.063 | 0.047 | 0.087 | Neutrophil collagenase inhibitor | 0.087 0.028 DBMET00088 | DBMET00088 | |
| 0.043 | 0.029 | 0.049 | GHS receptor agonist | 0.049 0.021 DBMET00088 | DBMET00088 | |
| 0.033 | 0.02 | 0.038 | GHS receptor antagonist | 0.038 0.014 DBMET00088 | DBMET00088 | |
| 0.059 | 0.046 | 0.059 | Dopamine D3 antagonist | |||
| 0.043 | 0.03 | 0.047 | GABA B receptor antagonist | 0.047 0.023 DBMET00088 | DBMET00088 | |
| 0.141 | 0.13 | 0.141 | Catenin beta inhibitor | |||
| 0.028 | 0.017 | 0.029 | Urotensin II agonist | 0.029 0.016 DBMET00088 0.024 0.023 DBMET00089 | DBMET00088 | |
| 0.078 | 0.071 | 0.09 | Factor XII inhibitor | 0.09 0.049 DBMET00088 | DBMET00088 | |
| 0.057 | 0.05 | 0.074 | Glucagon-like peptide 1 agonist | 0.074 0.039 DBMET00088 | DBMET00088 | |
| 0.054 | 0.049 | 0.061 | Collagenase 3 inhibitor | 0.061 0.04 DBMET00088 | DBMET00088 | |
| 0.052 | 0.048 | 0.052 | Alpha 1 adrenoreceptor agonist | |||
| 0.089 | 0.086 | 0.089 | Alpha 2b adrenoreceptor antagonist | |||
| 0.027 | 0.024 | 0.028 | Liver X receptor alpha antagonist | 0.028 0.022 DBMET00088 | DBMET00088 | |
| 0.087 | 0.084 | 0.12 | Nitric-oxide synthase inhibitor | 0.12 0.038 DBMET00088 | DBMET00088 | |
| 0.015 | 0.012 | 0.015 | CC chemokine 10 receptor antagonist | |||
| 0.031 | 0.028 | 0.037 | Growth hormone secretagogue receptor antagonist | 0.037 0.024 DBMET00088 | DBMET00088 | |
| 0.019 | 0.016 | 0.02 | Follicle-stimulating hormone antagonist | 0.02 0.013 DBMET00088 | DBMET00088 | |
| 0.049 | 0.048 | 0.049 | Bromodomain-containing protein 4 inhibitor | |||
| 0.051 | 0.051 | 0.129 | CXC chemokine 4 receptor antagonist | 0.129 0.019 DBMET00088 | DBMET00088 | |
| 0.017 | 0.018 | 0.022 | Somatostatin 3 agonist | 0.022 0.008 DBMET00088 | DBMET00088 | |
| 0.027 | 0.027 | 0.028 | Liver X receptor antagonist | 0.028 0.025 DBMET00088 | DBMET00088 | |
| 0.022 | 0.024 | 0.039 | Melanocortin 3 antagonist | 0.039 0.017 DBMET00088 | DBMET00088 | |
| 0.038 | 0.041 | 0.04 | Liver X receptor agonist | 0.04 0.035 DBMET00088 | DBMET00088 | |
| 0.015 | 0.018 | 0.034 | Melatonin 3 antagonist | 0.034 0.008 DBMET00088 | DBMET00088 | |
| 0.04 | 0.046 | 0.057 | Metalloproteinase-3 inhibitor | 0.057 0.026 DBMET00088 | DBMET00088 | |
| 0.017 | 0.023 | 0.022 | Growth hormone releasing factor antagonist | 0.022 0.018 DBMET00088 | DBMET00088 | |
| 0.023 | 0.031 | 0.027 | Histone deacetylase class IV inhibitor | 0.027 0.026 DBMET00088 | DBMET00088 | |
| 0.023 | 0.031 | 0.027 | Histone deacetylase 11 inhibitor | 0.027 0.026 DBMET00088 | DBMET00088 | |
| 0.049 | 0.058 | 0.07 | 5 Hydroxytryptamine uptake inhibitor | 0.07 0.039 DBMET00088 | DBMET00088 | |
| 0.034 | 0.045 | 0.067 | Phenylethanolamine N methyltransferase inhibitor | 0.067 0.005 DBMET00088 | DBMET00088 | |
| 0.019 | 0.031 | 0.023 | Melanocortin 5 antagonist | 0.023 0.021 DBMET00088 | DBMET00088 | |
| 0.048 | 0.06 | 0.054 | Bombesin 1 receptor agonist | 0.054 0.049 DBMET00088 | DBMET00088 | |
| 0.027 | 0.041 | 0.043 | Melanocortin 1 antagonist | 0.043 0.023 DBMET00088 | DBMET00088 | |
| 0.006 | 0.02 | 0.011 | Melatonin 5 antagonist | 0.011 0.009 DBMET00088 | DBMET00088 | |
| 0.182 | 0.202 | 0.2 | Antithrombotic | 0.2 0.177 DBMET00088 | DBMET00088 | |
| 0.056 | 0.076 | 0.085 | CXC chemokine receptor antagonist | 0.085 0.033 DBMET00088 | DBMET00088 | |
| 0.027 | 0.051 | 0.047 | Histone deacetylase 8 inhibitor | 0.047 0.024 DBMET00088 | DBMET00088 | |
| 0.106 | 0.132 | 0.127 | Anticoagulant | 0.127 0.103 DBMET00088 | DBMET00088 | |
| 0.117 | 0.158 | 0.16 | DNA methylase inhibitor | 0.16 0.109 DBMET00088 | DBMET00088 | |
| 0.036 | 0.089 | 0.058 | 5 Hydroxytryptamine 2A agonist | 0.058 0.049 DBMET00088 | DBMET00088 | |
| 0.053 | 0.112 | 0.132 | Adrenaline agonist | 0.132 0.021 DBMET00088 | DBMET00088 | |
| 0.012 | 0.073 | 0.021 | Motilin receptor agonist | 0.021 0.019 DBMET00088 | DBMET00088 | |
| 0.097 | 0.163 | 0.15 | Angiogenesis stimulant | 0.15 0.123 DBMET00088 | DBMET00088 | |
| 0.047 | 0.113 | 0.073 | Beta 3 adrenoreceptor antagonist | 0.073 0.029 DBMET00088 | DBMET00088 | |
| 0.158 | 0.263 | 0.488 | Toll-Like receptor 7 agonist | 0.488 0.034 DBMET00089 | DBMET00089 | |
| 0.157 | 0.265 | 0.485 | Toll-Like receptor agonist | 0.485 0.035 DBMET00089 | DBMET00089 | |
| 0.082 | 0.191 | 0.121 | Phospholipase A2 inhibitor | 0.121 0.116 DBMET00088 | DBMET00088 | |
| 0.165 | 0.276 | 0.216 | Calcium channel activator | 0.216 0.191 DBMET00088 | DBMET00088 | |
| 0.054 | 0.184 | 0.227 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.227 0.034 DBMET00089 | DBMET00089 | |
| 0.022 | 0.156 | 0.055 | Beta 2 adrenoreceptor antagonist | 0.055 0.029 DBMET00088 | DBMET00088 | |
| 0.028 | 0.165 | 0.045 | Beta adrenoreceptor agonist | 0.045 0.032 DBMET00088 | DBMET00088 | |
| 0.027 | 0.33 | 0.135 | Bronchodilator | 0.135 0.037 DBMET00089 | DBMET00089 | |
| 0.03 | 0.557 | 0.193 | Tumour necrosis factor alpha release inhibitor | 0.193 0.115 DBMET00089 | DBMET00089 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |